nodes	percent_of_prediction	percent_of_DWPC	metapath
Guanfacine—CYP2C9—Capecitabine—esophageal cancer	0.0224	0.665	CbGbCtD
Guanfacine—Abdominal pain lower—Capecitabine—esophageal cancer	0.0204	0.0381	CcSEcCtD
Guanfacine—Paresis—Methotrexate—esophageal cancer	0.0132	0.0247	CcSEcCtD
Guanfacine—CYP2C9—Cisplatin—esophageal cancer	0.0113	0.335	CbGbCtD
Guanfacine—Loss of libido—Methotrexate—esophageal cancer	0.0105	0.0195	CcSEcCtD
Guanfacine—Skin exfoliation—Cisplatin—esophageal cancer	0.0084	0.0157	CcSEcCtD
Guanfacine—Cardiac failure congestive—Cisplatin—esophageal cancer	0.00705	0.0131	CcSEcCtD
Guanfacine—Nocturia—Capecitabine—esophageal cancer	0.00699	0.0131	CcSEcCtD
Guanfacine—Renal failure acute—Cisplatin—esophageal cancer	0.00692	0.0129	CcSEcCtD
Guanfacine—Amnesia—Cisplatin—esophageal cancer	0.0068	0.0127	CcSEcCtD
Guanfacine—Cerebrovascular accident—Cisplatin—esophageal cancer	0.00652	0.0122	CcSEcCtD
Guanfacine—Urinary incontinence—Capecitabine—esophageal cancer	0.00627	0.0117	CcSEcCtD
Guanfacine—Skin exfoliation—Capecitabine—esophageal cancer	0.00619	0.0116	CcSEcCtD
Guanfacine—Diclofenac—PTGS1—esophageal cancer	0.00613	0.486	CrCbGaD
Guanfacine—Irritability—Cisplatin—esophageal cancer	0.0061	0.0114	CcSEcCtD
Guanfacine—Orthostatic hypotension—Cisplatin—esophageal cancer	0.00584	0.0109	CcSEcCtD
Guanfacine—Abdominal discomfort—Cisplatin—esophageal cancer	0.00529	0.00988	CcSEcCtD
Guanfacine—Vascular purpura—Capecitabine—esophageal cancer	0.00526	0.00982	CcSEcCtD
Guanfacine—Renal failure acute—Capecitabine—esophageal cancer	0.0051	0.00952	CcSEcCtD
Guanfacine—Amnesia—Capecitabine—esophageal cancer	0.00501	0.00935	CcSEcCtD
Guanfacine—Dermatitis exfoliative—Capecitabine—esophageal cancer	0.00499	0.00931	CcSEcCtD
Guanfacine—Purpura—Capecitabine—esophageal cancer	0.00489	0.00912	CcSEcCtD
Guanfacine—Acute coronary syndrome—Cisplatin—esophageal cancer	0.00485	0.00906	CcSEcCtD
Guanfacine—Myocardial infarction—Cisplatin—esophageal cancer	0.00483	0.00901	CcSEcCtD
Guanfacine—Cerebrovascular accident—Capecitabine—esophageal cancer	0.00481	0.00897	CcSEcCtD
Guanfacine—Lethargy—Capecitabine—esophageal cancer	0.00481	0.00897	CcSEcCtD
Guanfacine—Conjunctivitis—Cisplatin—esophageal cancer	0.00479	0.00893	CcSEcCtD
Guanfacine—Pain in extremity—Capecitabine—esophageal cancer	0.00471	0.00879	CcSEcCtD
Guanfacine—Skin exfoliation—Methotrexate—esophageal cancer	0.00461	0.0086	CcSEcCtD
Guanfacine—Bradycardia—Cisplatin—esophageal cancer	0.0045	0.0084	CcSEcCtD
Guanfacine—Irritability—Capecitabine—esophageal cancer	0.0045	0.00839	CcSEcCtD
Guanfacine—Liver function test abnormal—Capecitabine—esophageal cancer	0.00435	0.00811	CcSEcCtD
Guanfacine—Orthostatic hypotension—Capecitabine—esophageal cancer	0.0043	0.00803	CcSEcCtD
Guanfacine—Abdominal pain upper—Capecitabine—esophageal cancer	0.0043	0.00803	CcSEcCtD
Guanfacine—Visual impairment—Cisplatin—esophageal cancer	0.00426	0.00795	CcSEcCtD
Guanfacine—Alanine aminotransferase increased—Capecitabine—esophageal cancer	0.00415	0.00775	CcSEcCtD
Guanfacine—Eye disorder—Cisplatin—esophageal cancer	0.00413	0.00771	CcSEcCtD
Guanfacine—Tinnitus—Cisplatin—esophageal cancer	0.00412	0.00769	CcSEcCtD
Guanfacine—Dysphagia—Capecitabine—esophageal cancer	0.00407	0.0076	CcSEcCtD
Guanfacine—Asthma—Capecitabine—esophageal cancer	0.00407	0.0076	CcSEcCtD
Guanfacine—Immune system disorder—Cisplatin—esophageal cancer	0.00399	0.00745	CcSEcCtD
Guanfacine—Alopecia—Cisplatin—esophageal cancer	0.00391	0.00729	CcSEcCtD
Guanfacine—Abdominal discomfort—Capecitabine—esophageal cancer	0.0039	0.00728	CcSEcCtD
Guanfacine—Renal failure acute—Methotrexate—esophageal cancer	0.0038	0.00709	CcSEcCtD
Guanfacine—Dermatitis exfoliative—Methotrexate—esophageal cancer	0.00372	0.00693	CcSEcCtD
Guanfacine—Weight increased—Capecitabine—esophageal cancer	0.0037	0.00691	CcSEcCtD
Guanfacine—Muscle spasms—Cisplatin—esophageal cancer	0.0037	0.0069	CcSEcCtD
Guanfacine—Vision blurred—Cisplatin—esophageal cancer	0.00363	0.00677	CcSEcCtD
Guanfacine—Tremor—Cisplatin—esophageal cancer	0.0036	0.00673	CcSEcCtD
Guanfacine—Acute coronary syndrome—Capecitabine—esophageal cancer	0.00358	0.00668	CcSEcCtD
Guanfacine—Lethargy—Methotrexate—esophageal cancer	0.00358	0.00668	CcSEcCtD
Guanfacine—Cerebrovascular accident—Methotrexate—esophageal cancer	0.00358	0.00668	CcSEcCtD
Guanfacine—Ill-defined disorder—Cisplatin—esophageal cancer	0.00357	0.00666	CcSEcCtD
Guanfacine—Myocardial infarction—Capecitabine—esophageal cancer	0.00356	0.00664	CcSEcCtD
Guanfacine—Conjunctivitis—Capecitabine—esophageal cancer	0.00353	0.00658	CcSEcCtD
Guanfacine—Diclofenac—PTGS2—esophageal cancer	0.00351	0.278	CrCbGaD
Guanfacine—Malaise—Cisplatin—esophageal cancer	0.00347	0.00647	CcSEcCtD
Guanfacine—Irritability—Methotrexate—esophageal cancer	0.00335	0.00624	CcSEcCtD
Guanfacine—Convulsion—Cisplatin—esophageal cancer	0.00333	0.00622	CcSEcCtD
Guanfacine—Bradycardia—Capecitabine—esophageal cancer	0.00332	0.00619	CcSEcCtD
Guanfacine—Myalgia—Cisplatin—esophageal cancer	0.00328	0.00611	CcSEcCtD
Guanfacine—Rhinitis—Capecitabine—esophageal cancer	0.00327	0.00609	CcSEcCtD
Guanfacine—Anxiety—Cisplatin—esophageal cancer	0.00326	0.00609	CcSEcCtD
Guanfacine—Liver function test abnormal—Methotrexate—esophageal cancer	0.00324	0.00604	CcSEcCtD
Guanfacine—Discomfort—Cisplatin—esophageal cancer	0.00324	0.00604	CcSEcCtD
Guanfacine—Oedema—Cisplatin—esophageal cancer	0.00314	0.00586	CcSEcCtD
Guanfacine—Visual impairment—Capecitabine—esophageal cancer	0.00314	0.00586	CcSEcCtD
Guanfacine—Tachycardia—Cisplatin—esophageal cancer	0.00306	0.00572	CcSEcCtD
Guanfacine—Eye disorder—Capecitabine—esophageal cancer	0.00304	0.00568	CcSEcCtD
Guanfacine—Tinnitus—Capecitabine—esophageal cancer	0.00304	0.00567	CcSEcCtD
Guanfacine—Hyperhidrosis—Cisplatin—esophageal cancer	0.00304	0.00566	CcSEcCtD
Guanfacine—Asthma—Methotrexate—esophageal cancer	0.00303	0.00565	CcSEcCtD
Guanfacine—Diclofenac—ABCB1—esophageal cancer	0.00298	0.236	CrCbGaD
Guanfacine—Immune system disorder—Capecitabine—esophageal cancer	0.00294	0.00549	CcSEcCtD
Guanfacine—Hypotension—Cisplatin—esophageal cancer	0.00293	0.00548	CcSEcCtD
Guanfacine—Abdominal discomfort—Methotrexate—esophageal cancer	0.00291	0.00542	CcSEcCtD
Guanfacine—Alopecia—Capecitabine—esophageal cancer	0.00288	0.00537	CcSEcCtD
Guanfacine—Musculoskeletal discomfort—Cisplatin—esophageal cancer	0.00286	0.00534	CcSEcCtD
Guanfacine—Paraesthesia—Cisplatin—esophageal cancer	0.00282	0.00526	CcSEcCtD
Guanfacine—Dyspnoea—Cisplatin—esophageal cancer	0.0028	0.00522	CcSEcCtD
Guanfacine—Erectile dysfunction—Methotrexate—esophageal cancer	0.00279	0.00521	CcSEcCtD
Guanfacine—Dysgeusia—Capecitabine—esophageal cancer	0.00278	0.00518	CcSEcCtD
Guanfacine—Decreased appetite—Cisplatin—esophageal cancer	0.00273	0.00509	CcSEcCtD
Guanfacine—Muscle spasms—Capecitabine—esophageal cancer	0.00273	0.00509	CcSEcCtD
Guanfacine—Drowsiness—Methotrexate—esophageal cancer	0.0027	0.00504	CcSEcCtD
Guanfacine—Vision blurred—Capecitabine—esophageal cancer	0.00267	0.00499	CcSEcCtD
Guanfacine—Tremor—Capecitabine—esophageal cancer	0.00266	0.00496	CcSEcCtD
Guanfacine—Ill-defined disorder—Capecitabine—esophageal cancer	0.00263	0.00491	CcSEcCtD
Guanfacine—Conjunctivitis—Methotrexate—esophageal cancer	0.00263	0.0049	CcSEcCtD
Guanfacine—Sweating—Methotrexate—esophageal cancer	0.00259	0.00483	CcSEcCtD
Guanfacine—Feeling abnormal—Cisplatin—esophageal cancer	0.00259	0.00483	CcSEcCtD
Guanfacine—Malaise—Capecitabine—esophageal cancer	0.00256	0.00477	CcSEcCtD
Guanfacine—Vertigo—Capecitabine—esophageal cancer	0.00255	0.00475	CcSEcCtD
Guanfacine—Syncope—Capecitabine—esophageal cancer	0.00254	0.00475	CcSEcCtD
Guanfacine—Palpitations—Capecitabine—esophageal cancer	0.00251	0.00468	CcSEcCtD
Guanfacine—Loss of consciousness—Capecitabine—esophageal cancer	0.00249	0.00465	CcSEcCtD
Guanfacine—Hypertension—Capecitabine—esophageal cancer	0.00245	0.00457	CcSEcCtD
Guanfacine—Chest pain—Capecitabine—esophageal cancer	0.00241	0.00451	CcSEcCtD
Guanfacine—Myalgia—Capecitabine—esophageal cancer	0.00241	0.00451	CcSEcCtD
Guanfacine—Arthralgia—Capecitabine—esophageal cancer	0.00241	0.00451	CcSEcCtD
Guanfacine—Anxiety—Capecitabine—esophageal cancer	0.00241	0.00449	CcSEcCtD
Guanfacine—Discomfort—Capecitabine—esophageal cancer	0.00239	0.00445	CcSEcCtD
Guanfacine—Dry mouth—Capecitabine—esophageal cancer	0.00236	0.00441	CcSEcCtD
Guanfacine—Visual impairment—Methotrexate—esophageal cancer	0.00234	0.00436	CcSEcCtD
Guanfacine—Confusional state—Capecitabine—esophageal cancer	0.00233	0.00436	CcSEcCtD
Guanfacine—Oedema—Capecitabine—esophageal cancer	0.00231	0.00432	CcSEcCtD
Guanfacine—Hypersensitivity—Cisplatin—esophageal cancer	0.00231	0.00432	CcSEcCtD
Guanfacine—Shock—Capecitabine—esophageal cancer	0.00228	0.00425	CcSEcCtD
Guanfacine—Eye disorder—Methotrexate—esophageal cancer	0.00227	0.00423	CcSEcCtD
Guanfacine—Tinnitus—Methotrexate—esophageal cancer	0.00226	0.00422	CcSEcCtD
Guanfacine—Tachycardia—Capecitabine—esophageal cancer	0.00226	0.00422	CcSEcCtD
Guanfacine—Asthenia—Cisplatin—esophageal cancer	0.00225	0.0042	CcSEcCtD
Guanfacine—Hyperhidrosis—Capecitabine—esophageal cancer	0.00224	0.00418	CcSEcCtD
Guanfacine—Immune system disorder—Methotrexate—esophageal cancer	0.00219	0.00409	CcSEcCtD
Guanfacine—Hypotension—Capecitabine—esophageal cancer	0.00216	0.00404	CcSEcCtD
Guanfacine—Diarrhoea—Cisplatin—esophageal cancer	0.00215	0.00401	CcSEcCtD
Guanfacine—Alopecia—Methotrexate—esophageal cancer	0.00214	0.004	CcSEcCtD
Guanfacine—Musculoskeletal discomfort—Capecitabine—esophageal cancer	0.00211	0.00394	CcSEcCtD
Guanfacine—Insomnia—Capecitabine—esophageal cancer	0.00209	0.00391	CcSEcCtD
Guanfacine—Paraesthesia—Capecitabine—esophageal cancer	0.00208	0.00388	CcSEcCtD
Guanfacine—Dysgeusia—Methotrexate—esophageal cancer	0.00207	0.00386	CcSEcCtD
Guanfacine—Dyspnoea—Capecitabine—esophageal cancer	0.00206	0.00385	CcSEcCtD
Guanfacine—Dyspepsia—Capecitabine—esophageal cancer	0.00204	0.0038	CcSEcCtD
Guanfacine—Decreased appetite—Capecitabine—esophageal cancer	0.00201	0.00375	CcSEcCtD
Guanfacine—Vomiting—Cisplatin—esophageal cancer	0.002	0.00373	CcSEcCtD
Guanfacine—Fatigue—Capecitabine—esophageal cancer	0.002	0.00372	CcSEcCtD
Guanfacine—Vision blurred—Methotrexate—esophageal cancer	0.00199	0.00371	CcSEcCtD
Guanfacine—Rash—Cisplatin—esophageal cancer	0.00198	0.00369	CcSEcCtD
Guanfacine—Constipation—Capecitabine—esophageal cancer	0.00198	0.00369	CcSEcCtD
Guanfacine—Dermatitis—Cisplatin—esophageal cancer	0.00198	0.00369	CcSEcCtD
Guanfacine—Ill-defined disorder—Methotrexate—esophageal cancer	0.00196	0.00366	CcSEcCtD
Guanfacine—Feeling abnormal—Capecitabine—esophageal cancer	0.00191	0.00356	CcSEcCtD
Guanfacine—Malaise—Methotrexate—esophageal cancer	0.0019	0.00355	CcSEcCtD
Guanfacine—Vertigo—Methotrexate—esophageal cancer	0.0019	0.00354	CcSEcCtD
Guanfacine—Gastrointestinal pain—Capecitabine—esophageal cancer	0.00189	0.00353	CcSEcCtD
Guanfacine—Nausea—Cisplatin—esophageal cancer	0.00187	0.00348	CcSEcCtD
Guanfacine—Abdominal pain—Capecitabine—esophageal cancer	0.00183	0.00341	CcSEcCtD
Guanfacine—Convulsion—Methotrexate—esophageal cancer	0.00183	0.00341	CcSEcCtD
Guanfacine—Arthralgia—Methotrexate—esophageal cancer	0.0018	0.00335	CcSEcCtD
Guanfacine—Myalgia—Methotrexate—esophageal cancer	0.0018	0.00335	CcSEcCtD
Guanfacine—Chest pain—Methotrexate—esophageal cancer	0.0018	0.00335	CcSEcCtD
Guanfacine—Discomfort—Methotrexate—esophageal cancer	0.00178	0.00331	CcSEcCtD
Guanfacine—Confusional state—Methotrexate—esophageal cancer	0.00174	0.00324	CcSEcCtD
Guanfacine—Hypersensitivity—Capecitabine—esophageal cancer	0.00171	0.00318	CcSEcCtD
Guanfacine—Hyperhidrosis—Methotrexate—esophageal cancer	0.00167	0.00311	CcSEcCtD
Guanfacine—Asthenia—Capecitabine—esophageal cancer	0.00166	0.0031	CcSEcCtD
Guanfacine—Pruritus—Capecitabine—esophageal cancer	0.00164	0.00306	CcSEcCtD
Guanfacine—Hypotension—Methotrexate—esophageal cancer	0.00161	0.003	CcSEcCtD
Guanfacine—Diarrhoea—Capecitabine—esophageal cancer	0.00158	0.00296	CcSEcCtD
Guanfacine—Musculoskeletal discomfort—Methotrexate—esophageal cancer	0.00157	0.00293	CcSEcCtD
Guanfacine—Insomnia—Methotrexate—esophageal cancer	0.00156	0.00291	CcSEcCtD
Guanfacine—Paraesthesia—Methotrexate—esophageal cancer	0.00155	0.00289	CcSEcCtD
Guanfacine—Dyspnoea—Methotrexate—esophageal cancer	0.00154	0.00287	CcSEcCtD
Guanfacine—Somnolence—Methotrexate—esophageal cancer	0.00153	0.00286	CcSEcCtD
Guanfacine—Dizziness—Capecitabine—esophageal cancer	0.00153	0.00286	CcSEcCtD
Guanfacine—Dyspepsia—Methotrexate—esophageal cancer	0.00152	0.00283	CcSEcCtD
Guanfacine—Decreased appetite—Methotrexate—esophageal cancer	0.0015	0.0028	CcSEcCtD
Guanfacine—Fatigue—Methotrexate—esophageal cancer	0.00149	0.00277	CcSEcCtD
Guanfacine—Vomiting—Capecitabine—esophageal cancer	0.00147	0.00275	CcSEcCtD
Guanfacine—Rash—Capecitabine—esophageal cancer	0.00146	0.00272	CcSEcCtD
Guanfacine—Dermatitis—Capecitabine—esophageal cancer	0.00146	0.00272	CcSEcCtD
Guanfacine—Headache—Capecitabine—esophageal cancer	0.00145	0.00271	CcSEcCtD
Guanfacine—Feeling abnormal—Methotrexate—esophageal cancer	0.00142	0.00265	CcSEcCtD
Guanfacine—Gastrointestinal pain—Methotrexate—esophageal cancer	0.00141	0.00263	CcSEcCtD
Guanfacine—Nausea—Capecitabine—esophageal cancer	0.00137	0.00257	CcSEcCtD
Guanfacine—Abdominal pain—Methotrexate—esophageal cancer	0.00136	0.00254	CcSEcCtD
Guanfacine—Hypersensitivity—Methotrexate—esophageal cancer	0.00127	0.00237	CcSEcCtD
Guanfacine—Asthenia—Methotrexate—esophageal cancer	0.00124	0.00231	CcSEcCtD
Guanfacine—Pruritus—Methotrexate—esophageal cancer	0.00122	0.00227	CcSEcCtD
Guanfacine—Diarrhoea—Methotrexate—esophageal cancer	0.00118	0.0022	CcSEcCtD
Guanfacine—Dizziness—Methotrexate—esophageal cancer	0.00114	0.00213	CcSEcCtD
Guanfacine—Vomiting—Methotrexate—esophageal cancer	0.0011	0.00204	CcSEcCtD
Guanfacine—Rash—Methotrexate—esophageal cancer	0.00109	0.00203	CcSEcCtD
Guanfacine—Dermatitis—Methotrexate—esophageal cancer	0.00109	0.00203	CcSEcCtD
Guanfacine—Headache—Methotrexate—esophageal cancer	0.00108	0.00201	CcSEcCtD
Guanfacine—Nausea—Methotrexate—esophageal cancer	0.00102	0.00191	CcSEcCtD
Guanfacine—ADRA2A—Metabolism—CA2—esophageal cancer	0.000361	0.000865	CbGpPWpGaD
Guanfacine—ADRA2A—Signaling by GPCR—AKAP13—esophageal cancer	0.00036	0.000863	CbGpPWpGaD
Guanfacine—ADRA2B—GPCR downstream signaling—GHRL—esophageal cancer	0.000353	0.000846	CbGpPWpGaD
Guanfacine—ADRA2A—GPCR downstream signaling—GNG7—esophageal cancer	0.000345	0.000827	CbGpPWpGaD
Guanfacine—ADRA2B—Signaling Pathways—CSNK1A1—esophageal cancer	0.000342	0.000818	CbGpPWpGaD
Guanfacine—ADRA2B—Signaling by GPCR—ANXA1—esophageal cancer	0.000339	0.00081	CbGpPWpGaD
Guanfacine—CYP2C9—Metabolism of lipids and lipoproteins—CRABP1—esophageal cancer	0.000338	0.000809	CbGpPWpGaD
Guanfacine—ADRA2A—Metabolism—PLCE1—esophageal cancer	0.000336	0.000804	CbGpPWpGaD
Guanfacine—ADRA2A—Metabolism—ADH7—esophageal cancer	0.000336	0.000804	CbGpPWpGaD
Guanfacine—ADRA2A—Signaling Pathways—ADCYAP1—esophageal cancer	0.00033	0.000791	CbGpPWpGaD
Guanfacine—ADRA2A—Hemostasis—ABL1—esophageal cancer	0.00033	0.00079	CbGpPWpGaD
Guanfacine—ADRA2A—Signaling by GPCR—PDE4D—esophageal cancer	0.00033	0.000789	CbGpPWpGaD
Guanfacine—ADRA2B—Signaling by GPCR—SST—esophageal cancer	0.000329	0.000788	CbGpPWpGaD
Guanfacine—CYP2C19—Metabolism—SLC52A3—esophageal cancer	0.000329	0.000788	CbGpPWpGaD
Guanfacine—CYP2C19—Metabolism—BLVRB—esophageal cancer	0.000329	0.000788	CbGpPWpGaD
Guanfacine—ADRA2B—Signaling by GPCR—GHRL—esophageal cancer	0.000321	0.000768	CbGpPWpGaD
Guanfacine—ADRA2B—Signaling Pathways—PFN1—esophageal cancer	0.00032	0.000765	CbGpPWpGaD
Guanfacine—ADRA2A—Signaling by GPCR—GNG7—esophageal cancer	0.000314	0.000751	CbGpPWpGaD
Guanfacine—ADRA2B—Hemostasis—NOS2—esophageal cancer	0.000313	0.00075	CbGpPWpGaD
Guanfacine—ADRA2A—GPCR downstream signaling—CXCL2—esophageal cancer	0.000304	0.000728	CbGpPWpGaD
Guanfacine—ADRA2A—Signaling Pathways—WWOX—esophageal cancer	0.000302	0.000723	CbGpPWpGaD
Guanfacine—CYP2C9—Metabolism—BLVRB—esophageal cancer	0.0003	0.000719	CbGpPWpGaD
Guanfacine—CYP2C9—Metabolism—SLC52A3—esophageal cancer	0.0003	0.000719	CbGpPWpGaD
Guanfacine—ADRA2A—Metabolism—ADH1B—esophageal cancer	0.000295	0.000705	CbGpPWpGaD
Guanfacine—CYP2C19—Metabolism of lipids and lipoproteins—PTGS1—esophageal cancer	0.000294	0.000705	CbGpPWpGaD
Guanfacine—ADRA2A—Signaling Pathways—FKBP1A—esophageal cancer	0.000287	0.000688	CbGpPWpGaD
Guanfacine—ADRA2B—Signaling Pathways—ELMO1—esophageal cancer	0.000287	0.000687	CbGpPWpGaD
Guanfacine—ADRA2A—GPCR downstream signaling—ANXA1—esophageal cancer	0.000283	0.000677	CbGpPWpGaD
Guanfacine—ADRA2A—Metabolism—TYMP—esophageal cancer	0.000282	0.000674	CbGpPWpGaD
Guanfacine—ADRA2B—Hemostasis—CREBBP—esophageal cancer	0.000281	0.000674	CbGpPWpGaD
Guanfacine—ADRA2A—Signaling Pathways—WIF1—esophageal cancer	0.000281	0.000673	CbGpPWpGaD
Guanfacine—ADRA2B—Signaling Pathways—AKAP13—esophageal cancer	0.000281	0.000672	CbGpPWpGaD
Guanfacine—CYP2C19—Metabolism—SLC10A2—esophageal cancer	0.00028	0.00067	CbGpPWpGaD
Guanfacine—CYP2C19—Metabolism—CA1—esophageal cancer	0.00028	0.00067	CbGpPWpGaD
Guanfacine—ADRA2A—Signaling by GPCR—CXCL2—esophageal cancer	0.000276	0.000661	CbGpPWpGaD
Guanfacine—ADRA2A—GPCR downstream signaling—SST—esophageal cancer	0.000275	0.000659	CbGpPWpGaD
Guanfacine—ADRA2B—Platelet activation, signaling and aggregation—PIK3CA—esophageal cancer	0.000275	0.000659	CbGpPWpGaD
Guanfacine—ADRA2A—Metabolism—CYP26A1—esophageal cancer	0.000274	0.000656	CbGpPWpGaD
Guanfacine—CYP2C9—Metabolism of lipids and lipoproteins—PTGS1—esophageal cancer	0.000268	0.000642	CbGpPWpGaD
Guanfacine—ADRA2A—GPCR downstream signaling—GHRL—esophageal cancer	0.000268	0.000642	CbGpPWpGaD
Guanfacine—ADRA2A—Metabolism—ALOX15—esophageal cancer	0.000267	0.000639	CbGpPWpGaD
Guanfacine—ADRA2A—Signaling Pathways—CSNK1A1—esophageal cancer	0.000259	0.000621	CbGpPWpGaD
Guanfacine—ADRA2B—Signaling Pathways—HIST1H2BM—esophageal cancer	0.000259	0.00062	CbGpPWpGaD
Guanfacine—ADRA2A—Signaling by GPCR—ANXA1—esophageal cancer	0.000257	0.000615	CbGpPWpGaD
Guanfacine—ADRA2B—Signaling Pathways—PDE4D—esophageal cancer	0.000257	0.000614	CbGpPWpGaD
Guanfacine—CYP2C19—Metabolism—CA2—esophageal cancer	0.000256	0.000613	CbGpPWpGaD
Guanfacine—CYP2C9—Metabolism—SLC10A2—esophageal cancer	0.000255	0.000611	CbGpPWpGaD
Guanfacine—CYP2C9—Metabolism—CA1—esophageal cancer	0.000255	0.000611	CbGpPWpGaD
Guanfacine—ADRA2A—Metabolism—TPI1—esophageal cancer	0.000255	0.00061	CbGpPWpGaD
Guanfacine—ADRA2A—Metabolism—GSTO1—esophageal cancer	0.000255	0.00061	CbGpPWpGaD
Guanfacine—ADRA2B—Hemostasis—NOS3—esophageal cancer	0.000252	0.000603	CbGpPWpGaD
Guanfacine—CYP2C19—Metabolism of lipids and lipoproteins—CYP1B1—esophageal cancer	0.00025	0.000599	CbGpPWpGaD
Guanfacine—ADRA2A—Signaling by GPCR—SST—esophageal cancer	0.00025	0.000598	CbGpPWpGaD
Guanfacine—ADRA2B—Signaling Pathways—GNG7—esophageal cancer	0.000244	0.000584	CbGpPWpGaD
Guanfacine—ADRA2A—Metabolism—ALDOB—esophageal cancer	0.000244	0.000584	CbGpPWpGaD
Guanfacine—ADRA2A—Signaling by GPCR—GHRL—esophageal cancer	0.000243	0.000583	CbGpPWpGaD
Guanfacine—ADRA2A—Signaling Pathways—PFN1—esophageal cancer	0.000243	0.000581	CbGpPWpGaD
Guanfacine—CYP2C19—Metabolism—ADH7—esophageal cancer	0.000238	0.00057	CbGpPWpGaD
Guanfacine—CYP2C19—Metabolism—PLCE1—esophageal cancer	0.000238	0.00057	CbGpPWpGaD
Guanfacine—ADRA2A—Hemostasis—NOS2—esophageal cancer	0.000238	0.000569	CbGpPWpGaD
Guanfacine—CYP2C19—Metabolism of lipids and lipoproteins—CYP19A1—esophageal cancer	0.000235	0.000563	CbGpPWpGaD
Guanfacine—ADRA2A—Metabolism—GAPDH—esophageal cancer	0.000235	0.000563	CbGpPWpGaD
Guanfacine—CYP2C9—Metabolism—CA2—esophageal cancer	0.000234	0.000559	CbGpPWpGaD
Guanfacine—ADRA2A—Metabolism—CRABP1—esophageal cancer	0.000233	0.000558	CbGpPWpGaD
Guanfacine—ADRA2B—Signaling Pathways—XIAP—esophageal cancer	0.000229	0.000548	CbGpPWpGaD
Guanfacine—CYP2C9—Metabolism of lipids and lipoproteins—CYP1B1—esophageal cancer	0.000228	0.000546	CbGpPWpGaD
Guanfacine—ADRA2A—Metabolism—GNG7—esophageal cancer	0.000222	0.00053	CbGpPWpGaD
Guanfacine—ADRA2A—Signaling Pathways—ELMO1—esophageal cancer	0.000218	0.000522	CbGpPWpGaD
Guanfacine—CYP2C9—Metabolism—PLCE1—esophageal cancer	0.000217	0.00052	CbGpPWpGaD
Guanfacine—CYP2C9—Metabolism—ADH7—esophageal cancer	0.000217	0.00052	CbGpPWpGaD
Guanfacine—ADRA2B—Signaling Pathways—CTNNA1—esophageal cancer	0.000216	0.000518	CbGpPWpGaD
Guanfacine—ADRA2B—Signaling Pathways—CXCL2—esophageal cancer	0.000215	0.000515	CbGpPWpGaD
Guanfacine—CYP2C9—Metabolism of lipids and lipoproteins—CYP19A1—esophageal cancer	0.000215	0.000514	CbGpPWpGaD
Guanfacine—ADRA2A—Hemostasis—CREBBP—esophageal cancer	0.000214	0.000511	CbGpPWpGaD
Guanfacine—ADRA2A—Signaling Pathways—AKAP13—esophageal cancer	0.000213	0.00051	CbGpPWpGaD
Guanfacine—CYP2C19—Metabolism—ADH1B—esophageal cancer	0.000209	0.0005	CbGpPWpGaD
Guanfacine—ADRA2A—Platelet activation, signaling and aggregation—PIK3CA—esophageal cancer	0.000209	0.0005	CbGpPWpGaD
Guanfacine—ADRA2A—Metabolism—ALDH2—esophageal cancer	0.000208	0.000497	CbGpPWpGaD
Guanfacine—ADRA2B—Signaling Pathways—PSME2—esophageal cancer	0.000201	0.000481	CbGpPWpGaD
Guanfacine—ADRA2B—Signaling Pathways—PSME1—esophageal cancer	0.000201	0.000481	CbGpPWpGaD
Guanfacine—ADRA2B—Signaling Pathways—ANXA1—esophageal cancer	0.0002	0.000479	CbGpPWpGaD
Guanfacine—CYP2C19—Metabolism—TYMP—esophageal cancer	0.0002	0.000478	CbGpPWpGaD
Guanfacine—CYP3A4—Metabolism—BLVRB—esophageal cancer	0.000198	0.000474	CbGpPWpGaD
Guanfacine—CYP3A4—Metabolism—SLC52A3—esophageal cancer	0.000198	0.000474	CbGpPWpGaD
Guanfacine—ADRA2A—Metabolism—GSTT1—esophageal cancer	0.000197	0.000473	CbGpPWpGaD
Guanfacine—ADRA2A—Signaling Pathways—HIST1H2BM—esophageal cancer	0.000197	0.00047	CbGpPWpGaD
Guanfacine—ADRA2A—Metabolism—CYP2A6—esophageal cancer	0.000195	0.000467	CbGpPWpGaD
Guanfacine—ADRA2A—Signaling Pathways—PDE4D—esophageal cancer	0.000195	0.000466	CbGpPWpGaD
Guanfacine—ADRA2B—Signaling Pathways—SST—esophageal cancer	0.000195	0.000466	CbGpPWpGaD
Guanfacine—CYP2C19—Metabolism—CYP26A1—esophageal cancer	0.000194	0.000465	CbGpPWpGaD
Guanfacine—ADRA2B—Hemostasis—EP300—esophageal cancer	0.000192	0.000459	CbGpPWpGaD
Guanfacine—ADRA2A—Hemostasis—NOS3—esophageal cancer	0.000191	0.000458	CbGpPWpGaD
Guanfacine—CYP2C9—Metabolism—ADH1B—esophageal cancer	0.00019	0.000456	CbGpPWpGaD
Guanfacine—ADRA2B—Signaling Pathways—NOTCH3—esophageal cancer	0.00019	0.000454	CbGpPWpGaD
Guanfacine—ADRA2B—Signaling Pathways—GHRL—esophageal cancer	0.00019	0.000454	CbGpPWpGaD
Guanfacine—CYP2C19—Metabolism—ALOX15—esophageal cancer	0.000189	0.000453	CbGpPWpGaD
Guanfacine—ADRA2B—Signaling Pathways—FBXW7—esophageal cancer	0.000187	0.000446	CbGpPWpGaD
Guanfacine—ADRA2A—Signaling Pathways—GNG7—esophageal cancer	0.000185	0.000443	CbGpPWpGaD
Guanfacine—ADRA2A—Metabolism—PTGS1—esophageal cancer	0.000185	0.000443	CbGpPWpGaD
Guanfacine—ADRA2A—Metabolism—ENO1—esophageal cancer	0.000185	0.000443	CbGpPWpGaD
Guanfacine—ADRA2A—Metabolism—PSME2—esophageal cancer	0.000182	0.000436	CbGpPWpGaD
Guanfacine—ADRA2A—Metabolism—PSME1—esophageal cancer	0.000182	0.000436	CbGpPWpGaD
Guanfacine—CYP2C9—Metabolism—TYMP—esophageal cancer	0.000182	0.000435	CbGpPWpGaD
Guanfacine—CYP2C19—Metabolism—GSTO1—esophageal cancer	0.00018	0.000432	CbGpPWpGaD
Guanfacine—CYP2C19—Metabolism—TPI1—esophageal cancer	0.00018	0.000432	CbGpPWpGaD
Guanfacine—CYP2C9—Metabolism—CYP26A1—esophageal cancer	0.000177	0.000424	CbGpPWpGaD
Guanfacine—ADRA2A—Signaling Pathways—XIAP—esophageal cancer	0.000174	0.000416	CbGpPWpGaD
Guanfacine—CYP2C19—Metabolism—ALDOB—esophageal cancer	0.000173	0.000414	CbGpPWpGaD
Guanfacine—CYP2C9—Metabolism—ALOX15—esophageal cancer	0.000172	0.000413	CbGpPWpGaD
Guanfacine—ADRA2B—Signaling Pathways—NOTCH2—esophageal cancer	0.00017	0.000407	CbGpPWpGaD
Guanfacine—CYP3A4—Metabolism—CA1—esophageal cancer	0.000168	0.000403	CbGpPWpGaD
Guanfacine—CYP3A4—Metabolism—SLC10A2—esophageal cancer	0.000168	0.000403	CbGpPWpGaD
Guanfacine—CYP2C19—Metabolism—GAPDH—esophageal cancer	0.000167	0.000399	CbGpPWpGaD
Guanfacine—CYP2C19—Metabolism—CRABP1—esophageal cancer	0.000165	0.000395	CbGpPWpGaD
Guanfacine—CYP2C9—Metabolism—GSTO1—esophageal cancer	0.000165	0.000394	CbGpPWpGaD
Guanfacine—CYP2C9—Metabolism—TPI1—esophageal cancer	0.000165	0.000394	CbGpPWpGaD
Guanfacine—ADRA2A—Signaling Pathways—CTNNA1—esophageal cancer	0.000164	0.000393	CbGpPWpGaD
Guanfacine—ADRA2A—Signaling Pathways—CXCL2—esophageal cancer	0.000163	0.000391	CbGpPWpGaD
Guanfacine—CYP2C9—Metabolism—ALDOB—esophageal cancer	0.000158	0.000378	CbGpPWpGaD
Guanfacine—ADRA2A—Metabolism—CYP1B1—esophageal cancer	0.000157	0.000377	CbGpPWpGaD
Guanfacine—CYP2C19—Metabolism—GNG7—esophageal cancer	0.000157	0.000376	CbGpPWpGaD
Guanfacine—CYP3A4—Metabolism—CA2—esophageal cancer	0.000154	0.000369	CbGpPWpGaD
Guanfacine—ADRA2A—Signaling Pathways—PSME1—esophageal cancer	0.000152	0.000365	CbGpPWpGaD
Guanfacine—ADRA2A—Signaling Pathways—PSME2—esophageal cancer	0.000152	0.000365	CbGpPWpGaD
Guanfacine—CYP2C9—Metabolism—GAPDH—esophageal cancer	0.000152	0.000363	CbGpPWpGaD
Guanfacine—ADRA2A—Signaling Pathways—ANXA1—esophageal cancer	0.000152	0.000363	CbGpPWpGaD
Guanfacine—ADRA2B—Signaling Pathways—TGFBR2—esophageal cancer	0.000151	0.000361	CbGpPWpGaD
Guanfacine—CYP2C9—Metabolism—CRABP1—esophageal cancer	0.00015	0.00036	CbGpPWpGaD
Guanfacine—ADRA2A—Metabolism—CYP19A1—esophageal cancer	0.000148	0.000354	CbGpPWpGaD
Guanfacine—ADRA2A—Signaling Pathways—SST—esophageal cancer	0.000148	0.000353	CbGpPWpGaD
Guanfacine—CYP2C19—Metabolism—ALDH2—esophageal cancer	0.000147	0.000352	CbGpPWpGaD
Guanfacine—ADRA2A—Hemostasis—EP300—esophageal cancer	0.000145	0.000348	CbGpPWpGaD
Guanfacine—ADRA2A—Signaling Pathways—GHRL—esophageal cancer	0.000144	0.000344	CbGpPWpGaD
Guanfacine—ADRA2A—Signaling Pathways—NOTCH3—esophageal cancer	0.000144	0.000344	CbGpPWpGaD
Guanfacine—CYP3A4—Metabolism—PLCE1—esophageal cancer	0.000143	0.000343	CbGpPWpGaD
Guanfacine—CYP3A4—Metabolism—ADH7—esophageal cancer	0.000143	0.000343	CbGpPWpGaD
Guanfacine—CYP2C9—Metabolism—GNG7—esophageal cancer	0.000143	0.000343	CbGpPWpGaD
Guanfacine—ADRA2B—Signaling Pathways—SMAD4—esophageal cancer	0.000143	0.000342	CbGpPWpGaD
Guanfacine—ADRA2B—Hemostasis—PIK3CA—esophageal cancer	0.000142	0.000339	CbGpPWpGaD
Guanfacine—ADRA2A—Signaling Pathways—FBXW7—esophageal cancer	0.000142	0.000339	CbGpPWpGaD
Guanfacine—CYP2C19—Metabolism—GSTT1—esophageal cancer	0.00014	0.000335	CbGpPWpGaD
Guanfacine—CYP2C19—Metabolism—CYP2A6—esophageal cancer	0.000138	0.000331	CbGpPWpGaD
Guanfacine—CYP2C19—Metabolism of lipids and lipoproteins—CREBBP—esophageal cancer	0.000138	0.00033	CbGpPWpGaD
Guanfacine—ADRA2B—Hemostasis—TP53—esophageal cancer	0.000137	0.000328	CbGpPWpGaD
Guanfacine—ADRA2A—Metabolism—HMOX1—esophageal cancer	0.000135	0.000323	CbGpPWpGaD
Guanfacine—CYP2C9—Metabolism—ALDH2—esophageal cancer	0.000134	0.000321	CbGpPWpGaD
Guanfacine—CYP2C19—Metabolism—ENO1—esophageal cancer	0.000131	0.000314	CbGpPWpGaD
Guanfacine—CYP2C19—Metabolism—PTGS1—esophageal cancer	0.000131	0.000314	CbGpPWpGaD
Guanfacine—ADRA2A—Metabolism—ABCB1—esophageal cancer	0.00013	0.00031	CbGpPWpGaD
Guanfacine—CYP2C19—Metabolism—PSME1—esophageal cancer	0.000129	0.000309	CbGpPWpGaD
Guanfacine—CYP2C19—Metabolism—PSME2—esophageal cancer	0.000129	0.000309	CbGpPWpGaD
Guanfacine—ADRA2A—Signaling Pathways—NOTCH2—esophageal cancer	0.000129	0.000309	CbGpPWpGaD
Guanfacine—CYP2C9—Metabolism—GSTT1—esophageal cancer	0.000128	0.000305	CbGpPWpGaD
Guanfacine—CYP2C9—Metabolism—CYP2A6—esophageal cancer	0.000126	0.000302	CbGpPWpGaD
Guanfacine—CYP2C9—Metabolism of lipids and lipoproteins—CREBBP—esophageal cancer	0.000126	0.000301	CbGpPWpGaD
Guanfacine—CYP3A4—Metabolism—ADH1B—esophageal cancer	0.000126	0.0003	CbGpPWpGaD
Guanfacine—CYP3A4—Metabolism—TYMP—esophageal cancer	0.00012	0.000287	CbGpPWpGaD
Guanfacine—CYP2C9—Metabolism—ENO1—esophageal cancer	0.00012	0.000286	CbGpPWpGaD
Guanfacine—CYP2C9—Metabolism—PTGS1—esophageal cancer	0.00012	0.000286	CbGpPWpGaD
Guanfacine—CYP2C9—Metabolism—PSME1—esophageal cancer	0.000118	0.000282	CbGpPWpGaD
Guanfacine—CYP2C9—Metabolism—PSME2—esophageal cancer	0.000118	0.000282	CbGpPWpGaD
Guanfacine—ADRA2B—Signaling Pathways—HIF1A—esophageal cancer	0.000117	0.00028	CbGpPWpGaD
Guanfacine—CYP3A4—Metabolism—CYP26A1—esophageal cancer	0.000117	0.000279	CbGpPWpGaD
Guanfacine—ADRA2A—Signaling Pathways—TGFBR2—esophageal cancer	0.000114	0.000274	CbGpPWpGaD
Guanfacine—CYP3A4—Metabolism—ALOX15—esophageal cancer	0.000114	0.000272	CbGpPWpGaD
Guanfacine—CYP2C19—Metabolism of lipids and lipoproteins—PTGS2—esophageal cancer	0.000113	0.00027	CbGpPWpGaD
Guanfacine—ADRA2B—Signaling Pathways—KDR—esophageal cancer	0.000112	0.000267	CbGpPWpGaD
Guanfacine—CYP2C19—Metabolism—CYP1B1—esophageal cancer	0.000111	0.000267	CbGpPWpGaD
Guanfacine—CYP3A4—Metabolism—GSTO1—esophageal cancer	0.000108	0.00026	CbGpPWpGaD
Guanfacine—CYP3A4—Metabolism—TPI1—esophageal cancer	0.000108	0.00026	CbGpPWpGaD
Guanfacine—ADRA2A—Signaling Pathways—SMAD4—esophageal cancer	0.000108	0.000259	CbGpPWpGaD
Guanfacine—ADRA2A—Hemostasis—PIK3CA—esophageal cancer	0.000108	0.000258	CbGpPWpGaD
Guanfacine—ADRA2B—Signaling Pathways—NOTCH1—esophageal cancer	0.000105	0.000252	CbGpPWpGaD
Guanfacine—CYP2C19—Metabolism—CYP19A1—esophageal cancer	0.000105	0.000251	CbGpPWpGaD
Guanfacine—ADRA2A—Hemostasis—TP53—esophageal cancer	0.000104	0.000249	CbGpPWpGaD
Guanfacine—CYP3A4—Metabolism—ALDOB—esophageal cancer	0.000104	0.000249	CbGpPWpGaD
Guanfacine—CYP2C9—Metabolism of lipids and lipoproteins—PTGS2—esophageal cancer	0.000103	0.000246	CbGpPWpGaD
Guanfacine—CYP2C9—Metabolism—CYP1B1—esophageal cancer	0.000102	0.000243	CbGpPWpGaD
Guanfacine—CYP3A4—Metabolism—GAPDH—esophageal cancer	0.0001	0.00024	CbGpPWpGaD
Guanfacine—CYP3A4—Metabolism—CRABP1—esophageal cancer	9.92e-05	0.000238	CbGpPWpGaD
Guanfacine—CYP2C19—Metabolism—HMOX1—esophageal cancer	9.56e-05	0.000229	CbGpPWpGaD
Guanfacine—CYP2C9—Metabolism—CYP19A1—esophageal cancer	9.56e-05	0.000229	CbGpPWpGaD
Guanfacine—ADRA2B—Signaling Pathways—CREBBP—esophageal cancer	9.54e-05	0.000228	CbGpPWpGaD
Guanfacine—CYP3A4—Metabolism—GNG7—esophageal cancer	9.44e-05	0.000226	CbGpPWpGaD
Guanfacine—CYP2C19—Metabolism of lipids and lipoproteins—EP300—esophageal cancer	9.38e-05	0.000225	CbGpPWpGaD
Guanfacine—ADRA2B—Signaling by GPCR—EGFR—esophageal cancer	9.38e-05	0.000224	CbGpPWpGaD
Guanfacine—CYP2C19—Metabolism—ABCB1—esophageal cancer	9.18e-05	0.00022	CbGpPWpGaD
Guanfacine—ADRA2B—GPCR downstream signaling—PIK3CA—esophageal cancer	8.96e-05	0.000215	CbGpPWpGaD
Guanfacine—ADRA2A—Signaling Pathways—HIF1A—esophageal cancer	8.86e-05	0.000212	CbGpPWpGaD
Guanfacine—CYP3A4—Metabolism—ALDH2—esophageal cancer	8.84e-05	0.000212	CbGpPWpGaD
Guanfacine—CYP2C9—Metabolism—HMOX1—esophageal cancer	8.72e-05	0.000209	CbGpPWpGaD
Guanfacine—ADRA2A—Metabolism—CREBBP—esophageal cancer	8.66e-05	0.000207	CbGpPWpGaD
Guanfacine—CYP2C9—Metabolism of lipids and lipoproteins—EP300—esophageal cancer	8.55e-05	0.000205	CbGpPWpGaD
Guanfacine—ADRA2B—Signaling Pathways—NOS3—esophageal cancer	8.54e-05	0.000205	CbGpPWpGaD
Guanfacine—ADRA2A—Signaling Pathways—KDR—esophageal cancer	8.48e-05	0.000203	CbGpPWpGaD
Guanfacine—CYP3A4—Metabolism—GSTT1—esophageal cancer	8.41e-05	0.000201	CbGpPWpGaD
Guanfacine—CYP2C9—Metabolism—ABCB1—esophageal cancer	8.37e-05	0.0002	CbGpPWpGaD
Guanfacine—CYP3A4—Metabolism—CYP2A6—esophageal cancer	8.32e-05	0.000199	CbGpPWpGaD
Guanfacine—ADRA2B—Signaling by GPCR—PIK3CA—esophageal cancer	8.14e-05	0.000195	CbGpPWpGaD
Guanfacine—ADRA2B—Signaling Pathways—ERBB2—esophageal cancer	7.99e-05	0.000191	CbGpPWpGaD
Guanfacine—ADRA2A—Signaling Pathways—NOTCH1—esophageal cancer	7.99e-05	0.000191	CbGpPWpGaD
Guanfacine—CYP3A4—Metabolism—PTGS1—esophageal cancer	7.88e-05	0.000189	CbGpPWpGaD
Guanfacine—CYP3A4—Metabolism—ENO1—esophageal cancer	7.88e-05	0.000189	CbGpPWpGaD
Guanfacine—CYP3A4—Metabolism—PSME1—esophageal cancer	7.77e-05	0.000186	CbGpPWpGaD
Guanfacine—CYP3A4—Metabolism—PSME2—esophageal cancer	7.77e-05	0.000186	CbGpPWpGaD
Guanfacine—ADRA2A—Metabolism—NOS3—esophageal cancer	7.75e-05	0.000186	CbGpPWpGaD
Guanfacine—ADRA2A—Signaling Pathways—CREBBP—esophageal cancer	7.24e-05	0.000173	CbGpPWpGaD
Guanfacine—ADRA2A—Signaling by GPCR—EGFR—esophageal cancer	7.12e-05	0.00017	CbGpPWpGaD
Guanfacine—ADRA2A—Metabolism—PTGS2—esophageal cancer	7.09e-05	0.00017	CbGpPWpGaD
Guanfacine—ADRA2B—Signaling Pathways—CCND1—esophageal cancer	7.06e-05	0.000169	CbGpPWpGaD
Guanfacine—CYP2C19—Metabolism of lipids and lipoproteins—PIK3CA—esophageal cancer	6.94e-05	0.000166	CbGpPWpGaD
Guanfacine—ADRA2B—Signaling Pathways—CDKN1A—esophageal cancer	6.83e-05	0.000164	CbGpPWpGaD
Guanfacine—ADRA2A—GPCR downstream signaling—PIK3CA—esophageal cancer	6.8e-05	0.000163	CbGpPWpGaD
Guanfacine—CYP3A4—Metabolism—CYP1B1—esophageal cancer	6.7e-05	0.00016	CbGpPWpGaD
Guanfacine—ADRA2B—Signaling Pathways—EP300—esophageal cancer	6.5e-05	0.000156	CbGpPWpGaD
Guanfacine—ADRA2A—Signaling Pathways—NOS3—esophageal cancer	6.48e-05	0.000155	CbGpPWpGaD
Guanfacine—CYP2C9—Metabolism of lipids and lipoproteins—PIK3CA—esophageal cancer	6.33e-05	0.000151	CbGpPWpGaD
Guanfacine—CYP3A4—Metabolism—CYP19A1—esophageal cancer	6.3e-05	0.000151	CbGpPWpGaD
Guanfacine—ADRA2A—Signaling by GPCR—PIK3CA—esophageal cancer	6.18e-05	0.000148	CbGpPWpGaD
Guanfacine—CYP2C19—Metabolism—CREBBP—esophageal cancer	6.13e-05	0.000147	CbGpPWpGaD
Guanfacine—ADRA2A—Signaling Pathways—ERBB2—esophageal cancer	6.06e-05	0.000145	CbGpPWpGaD
Guanfacine—ADRA2A—Metabolism—EP300—esophageal cancer	5.9e-05	0.000141	CbGpPWpGaD
Guanfacine—CYP3A4—Metabolism—HMOX1—esophageal cancer	5.75e-05	0.000138	CbGpPWpGaD
Guanfacine—ADRA2B—Signaling Pathways—MYC—esophageal cancer	5.66e-05	0.000136	CbGpPWpGaD
Guanfacine—CYP2C9—Metabolism—CREBBP—esophageal cancer	5.59e-05	0.000134	CbGpPWpGaD
Guanfacine—ADRA2B—Signaling Pathways—EGFR—esophageal cancer	5.54e-05	0.000133	CbGpPWpGaD
Guanfacine—CYP3A4—Metabolism—ABCB1—esophageal cancer	5.52e-05	0.000132	CbGpPWpGaD
Guanfacine—CYP2C19—Metabolism—NOS3—esophageal cancer	5.49e-05	0.000131	CbGpPWpGaD
Guanfacine—ADRA2A—Signaling Pathways—CCND1—esophageal cancer	5.36e-05	0.000128	CbGpPWpGaD
Guanfacine—ADRA2A—Signaling Pathways—CDKN1A—esophageal cancer	5.18e-05	0.000124	CbGpPWpGaD
Guanfacine—CYP2C19—Metabolism—PTGS2—esophageal cancer	5.02e-05	0.00012	CbGpPWpGaD
Guanfacine—CYP2C9—Metabolism—NOS3—esophageal cancer	5.01e-05	0.00012	CbGpPWpGaD
Guanfacine—ADRA2A—Signaling Pathways—EP300—esophageal cancer	4.93e-05	0.000118	CbGpPWpGaD
Guanfacine—ADRA2B—Signaling Pathways—PIK3CA—esophageal cancer	4.81e-05	0.000115	CbGpPWpGaD
Guanfacine—ADRA2B—Signaling Pathways—TP53—esophageal cancer	4.65e-05	0.000111	CbGpPWpGaD
Guanfacine—CYP2C9—Metabolism—PTGS2—esophageal cancer	4.58e-05	0.00011	CbGpPWpGaD
Guanfacine—ADRA2A—Metabolism—PIK3CA—esophageal cancer	4.36e-05	0.000104	CbGpPWpGaD
Guanfacine—ADRA2A—Signaling Pathways—MYC—esophageal cancer	4.3e-05	0.000103	CbGpPWpGaD
Guanfacine—ADRA2A—Signaling Pathways—EGFR—esophageal cancer	4.2e-05	0.000101	CbGpPWpGaD
Guanfacine—CYP2C19—Metabolism—EP300—esophageal cancer	4.18e-05	0.0001	CbGpPWpGaD
Guanfacine—CYP2C9—Metabolism—EP300—esophageal cancer	3.81e-05	9.12e-05	CbGpPWpGaD
Guanfacine—CYP3A4—Metabolism—CREBBP—esophageal cancer	3.69e-05	8.83e-05	CbGpPWpGaD
Guanfacine—ADRA2A—Signaling Pathways—PIK3CA—esophageal cancer	3.65e-05	8.73e-05	CbGpPWpGaD
Guanfacine—ADRA2A—Signaling Pathways—TP53—esophageal cancer	3.53e-05	8.45e-05	CbGpPWpGaD
Guanfacine—CYP3A4—Metabolism—NOS3—esophageal cancer	3.3e-05	7.91e-05	CbGpPWpGaD
Guanfacine—CYP2C19—Metabolism—PIK3CA—esophageal cancer	3.09e-05	7.4e-05	CbGpPWpGaD
Guanfacine—CYP3A4—Metabolism—PTGS2—esophageal cancer	3.02e-05	7.23e-05	CbGpPWpGaD
Guanfacine—CYP2C9—Metabolism—PIK3CA—esophageal cancer	2.82e-05	6.75e-05	CbGpPWpGaD
Guanfacine—CYP3A4—Metabolism—EP300—esophageal cancer	2.51e-05	6.01e-05	CbGpPWpGaD
Guanfacine—CYP3A4—Metabolism—PIK3CA—esophageal cancer	1.86e-05	4.45e-05	CbGpPWpGaD
